Bilirubin is a superior biomarker for hepatocellular carcinoma diagnosis and for differential diagnosis of benign liver disease

Abstract

To develop a novel diagnostic model combining bilirubin, protein induced by vitamin K absence or antagonist-II (PIVKA-II), and alpha-fetoprotein (AFP) to improve hepatocellular carcinoma (HCC) diagnosis.

Keywords

• bilirubin
• alpha-fetoprotein
• protein induced by vitamin k absence or antagonist-ii
• benign liver disease
• hepatocellular carcinoma